Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Infinity Pharmaceuticals Inc INFIQ

Healthcare Biotechnology
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K... see more

Recent & Breaking News (GREY:INFIQ)

SHAREHOLDER ALERT: Weiss Law Reminds XM, INFI, WAYN, and INDT Shareholders About Its Ongoing Investigations

PR Newswire April 26, 2023

SHAREHOLDER ALERT: Weiss Law Reminds CVT, XM, INFI, and WAYN Shareholders About Its Ongoing Investigations

PR Newswire April 18, 2023

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO

PR Newswire April 17, 2023

Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research

Business Wire April 13, 2023

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TRTN, TESS, SHBI, INFI

PR Newswire April 12, 2023

SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, MLVF, and SHBI Shareholders About Its Ongoing Investigations

PR Newswire April 12, 2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, PRVB, INFI

PR Newswire March 30, 2023

SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, MLVF, and SHBI Shareholders About Its Ongoing Investigations

PR Newswire March 29, 2023

Infinity Pharmaceuticals Reports Full Year 2022 Financial Results

Business Wire March 28, 2023

SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, SUMO, and MLVF Shareholders About Its Ongoing Investigations

PR Newswire March 21, 2023

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TA, INDT, INFI, BRMK

PR Newswire March 14, 2023

SHAREHOLDER ALERT: Weiss Law Reminds INFI, INDT, DCP, and MLVF Shareholders About Its Ongoing Investigations

PR Newswire March 14, 2023

SHAREHOLDER ALERT: Weiss Law Reminds BRMK, FOCS, INFI, and INDT Shareholders About Its Ongoing Investigations

PR Newswire March 10, 2023

SHAREHOLDER ALERT: Weiss Law Reminds BRMK, FOCS, INFI, and INDT Shareholders About Its Ongoing Investigations

PR Newswire March 3, 2023

SHAREHOLDER ALERT: Weiss Law Investigates Infinity Pharmaceuticals, Inc.

PR Newswire February 28, 2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, JNCE, INFI, HRZN

PR Newswire February 28, 2023

STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Infinity Pharmaceuticals, Inc. - INFI

PR Newswire February 27, 2023

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Business Wire February 27, 2023

Moore Kuehn Encourages HRZN, INDT, INFI, and TA Investors to Contact Law Firm

PR Newswire February 24, 2023

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Infinity Pharmaceuticals, Inc. (INFI)

Newsfile February 23, 2023